关注
Camilo Rojas
Camilo Rojas
Assistant Professor, Johns Hopkins University
在 jhmi.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells
A Le, AN Lane, M Hamaker, S Bose, A Gouw, J Barbi, T Tsukamoto, ...
Cell metabolism 15 (1), 110-121, 2012
11802012
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1
MJ Seltzer, BD Bennett, AD Joshi, P Gao, AG Thomas, DV Ferraris, ...
Cancer research 70 (22), 8981-8987, 2010
5892010
Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1, 2, 4-thiadiazol-2-yl) ethyl sulfide (BPTES)
MM Robinson, SJ Mcbryant, T Tsukamoto, C Rojas, DV Ferraris, ...
Biochemical Journal 406 (3), 407-414, 2007
3702007
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic …
SY Cho, KL Gage, RC Mease, S Senthamizhchelvan, DP Holt, ...
Journal of Nuclear Medicine 53 (12), 1883-1891, 2012
3322012
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor
C Rojas, M Stathis, AG Thomas, EB Massuda, J Alt, J Zhang, ...
Anesthesia & Analgesia 107 (2), 469-478, 2008
2872008
Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer
C Barinka, C Rojas, B Slusher, M Pomper
Current medicinal chemistry 19 (6), 856-870, 2012
2462012
Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1, 2, 4-thiadiazol-2-yl) ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors
K Shukla, DV Ferraris, AG Thomas, M Stathis, B Duvall, G Delahanty, J Alt, ...
Journal of medicinal chemistry 55 (23), 10551-10563, 2012
2322012
Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function
C Rojas, AG Thomas, J Alt, M Stathis, J Zhang, EB Rubenstein, ...
European journal of pharmacology 626 (2-3), 193-199, 2010
2312010
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
A Elgogary, Q Xu, B Poore, J Alt, SC Zimmermann, L Zhao, J Fu, B Chen, ...
Proceedings of the National Academy of Sciences 113 (36), E5328-E5336, 2016
2232016
Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis
C Rojas, M Raje, T Tsukamoto, BS Slusher
European journal of pharmacology 722, 26-37, 2014
1782014
Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting
C Rojas, BS Slusher
European journal of pharmacology 684 (1-3), 1-7, 2012
1632012
Synthesis and Biological Evaluation of d-Amino Acid Oxidase Inhibitors
D Ferraris, B Duvall, YS Ko, AG Thomas, C Rojas, P Majer, K Hashimoto, ...
Journal of medicinal chemistry 51 (12), 3357-3359, 2008
1602008
Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor
P Majer, PF Jackson, G Delahanty, BS Grella, YS Ko, W Li, Q Liu, ...
Journal of medicinal chemistry 46 (10), 1989-1996, 2003
1562003
Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II
C Barinka, M Rinnová, P Šácha, C Rojas, P Majer, BS Slusher, ...
Journal of neurochemistry 80 (3), 477-487, 2002
1562002
The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo
C Rojas, Y Li, J Zhang, M Stathis, J Alt, AG Thomas, S Cantoreggi, ...
Journal of pharmacology and experimental therapeutics 335 (2), 362-368, 2010
1532010
Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models
GD Ghadge, BS Slusher, A Bodner, MD Canto, K Wozniak, AG Thomas, ...
Proceedings of the National Academy of Sciences 100 (16), 9554-9559, 2003
1442003
High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen
V Humblet, R Lapidus, LR Williams, T Tsukamoto, C Rojas, P Majer, B Hin, ...
Molecular imaging 4 (4), 7290.2005. 05163, 2005
1422005
Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen
Y Chen, M Pullambhatla, SR Banerjee, Y Byun, M Stathis, C Rojas, ...
Bioconjugate chemistry 23 (12), 2377-2385, 2012
1352012
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma
R Rais, A Jancarik, L Tenora, M Nedelcovych, J Alt, J Englert, C Rojas, ...
Journal of medicinal chemistry 59 (18), 8621-8633, 2016
1202016
Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders
MC Potter, M Figuera-Losada, C Rojas, BS Slusher
Journal of Neuroimmune Pharmacology 8, 594-607, 2013
1162013
系统目前无法执行此操作,请稍后再试。
文章 1–20